Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries

Objective: Obesity-linked type 2 diabetes (T2D) is a worldwide health concern and many novel approaches are being considered for its treatment and subsequent prevention of serious comorbidities. Co-administration of glucagon like peptide 1 (GLP-1) and peptide YY3-36 (PYY3-36) renders a synergistic d...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Brandon B. Boland (Egilea), Rhianna C. Laker (Egilea), Siobhan O'Brien (Egilea), Sadichha Sitaula (Egilea), Isabelle Sermadiras (Egilea), Jens Christian Nielsen (Egilea), Pernille Barkholt (Egilea), Urmas Roostalu (Egilea), Jacob Hecksher-Sørensen (Egilea), Sara Rubek Sejthen (Egilea), Ditte Dencker Thorbek (Egilea), Arthur Suckow (Egilea), Nicole Burmeister (Egilea), Stephanie Oldham (Egilea), Sarah Will (Egilea), Victor G. Howard (Egilea), Benji M. Gill (Egilea), Philip Newton (Egilea), Jacqueline Naylor (Egilea), David C. Hornigold (Egilea), Jotham Austin (Egilea), Louise Lantier (Egilea), Owen P. McGuinness (Egilea), James L. Trevaskis (Egilea), Joseph S. Grimsby (Egilea), Christopher J. Rhodes (Egilea)
Formatua: Liburua
Argitaratua: Elsevier, 2022-01-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri